At MSKCC, genetic breakthroughs have changed how medicine is practiced, revealing new ways to reduce cancer risk and improve the effectiveness of therapies.
Memorial Sloan-Kettering's Clinical Genetics Service has a staff of genetic counselors who offer information and education about genetic risk factors for individuals who have chosen to undergo genetic testing.
MSKCC announced the gift of a financial interest in Geoffrey Beene, LLC. Revenues generated by MSKCC's share in the company will be used to support the Geoffrey Beene Cancer Research Center.
Recent research has demonstrated that moderate exercise can help many individuals with breast cancer combat treatment-related fatigue and speed recovery.
In preclinical studies conducted by investigators at MSKCC and Columbia University, researchers have learned that vitamin C may reduce the effectiveness of certain anticancer drugs.
Scott Keeney, a member of the Molecular Biology Program within the Sloan-Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute investigator in 2008.
News@MSKCC provides journalists with news and information from Memorial Sloan-Kettering Cancer Center and is released six times a year.
For more information about these and other potential story ideas, contact Memorial Sloan-Kettering's Department of Public Affairs at: 212-639-3573 or at mediastaff@mskcc.org
